The independent source for health policy research, polling, and news.
The Physicians Committee for Responsible Medicine, which eschews meat and pushes for nutrition to have a stronger influence in health policy, is suggesting alterations in how food aid to low income people is structured.
Patients who depend on the state-run AIDS Drug Assistance Program are having trouble getting medical appointments and life-saving medications.
Covered California sent the wrong subsidy information to insurers, who charged most consumers less than they really owed. Now they have to pay up.
The designation, which is made by the Food and Drug Administration, allows drugmakers to claim seven years of market exclusivity.
Donald Trump’s pick to run HHS has been under fire for trading health care stocks but at least six senators at his confirmation hearings also own such stocks.
Federal officials release names of insurers who ranked poorly in a recent review of their online directories’ accuracy.
More hospitals, including Montefiore Medical Center in New York, are setting up support centers to help stressed-out family members cope.
Some lesser known provisions of the health law — things like calorie counts, lifetime limits and breast-feeding support — could be rolled back by repeal.
An analysis by the Congressional Budget Office offers an estimate of the effects of the repeal plan offered by congressional Republican in 2015, which may be a blueprint for efforts currently underway to overhaul the health law.
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
With the future of Obamacare on the line, workers might want to consider what benefits they have gained through the landmark law.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Ending federal support of the group that helps supply women’s reproductive health care could complicate health law overhaul efforts.
Follow the twists and turns of the orphan drug industry over the past three decades.
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
The former Congressman championed the Orphan Drug Act decades ago but now he fears it’s being manipulated to make money.
President-elect Donald Trump’s Cabinet pick Tom Price “assisted” a company and campaign donor who tapped executives with an urgent request to donate.
Two Pennsylvania voters who buy health insurance on healthcare.gov are frustrated with how expensive the plans have become. They voted for Trump in hopes he can bring down health insurance costs.
Price and another influential GOP congressman got a discounted deal as an Australian firm seeking federal approval sought “sophisticated U.S. investors.”
More than half a million people in North Carolina buy health insurance on healthcare.gov. Many are confused what will happen to their coverage as Republicans work to repeal the Affordable Care Act, but they still are signing up for 2017 plans.
